NUTRITIONAL FORMULATIONS
This invention relates to novel nutritional supplements comprising essential fatty acids and iron, as well as methods related thereto.
1 . A nutritional supplement comprising:
from about 50 mg to about 500 mg of calcium;
from about 100 mg to about 500 mg of omega-3 essential fatty acid from fish oil;
about 27 mg of carbonyl iron, soluble iron salts, slightly soluble iron salts, insoluble iron salts, chelated iron, iron complexes, and mixtures thereof;
from about 10 mg to about 300 mg of a linolenic acid compound, a linoleic acid compound, or a combination thereof;
about 25 mg of vitamin C;
from about 10 mg to about 150 mg of vitamin B 6 ; and
from about 0.5 mg to about 3 mg of folic acid, folate, a derivative or metabolite thereof;
wherein the nutritional supplement is provided in a soft gelatin shell dosage form.
2 . The nutritional supplement of claim 1 further comprising at least one additive selected from the group consisting of diluents, binders, adhesives, lubricants, plasticizers, disintegrants, colorants, bulking substances, flavorings, sweeteners, fragrances, aromatics, edible oils, polymers, buffers, adsorbents and mixtures thereof.
3 . The nutritional supplement of claim 1 wherein the weight ratio of the linolenic acid compound, linoleic acid compound, or combination thereof to the omega-3 fatty acid is about 1:0.1 to 10.
4 . The nutritional supplement of claim 1 wherein the weight ratio of the linolenic acid compound, linoleic acid compound, or combination thereof to the omega-3 fatty acid is about 1:0.09 to 2.5.
5 . The nutritional supplement of claim 1 wherein the weight ratio of the linolenic acid compound, linoleic acid compound, or combination thereof to the omega-3 fatty acid is about 1:1 to 2.
6 . The nutritional supplement of claim 1 wherein the calcium is selected from the group consisting of calcium carbonate, dicalcium phosphate, tricalcium phosphate, and combinations thereof.
7 . The nutritional supplement of claim 1 wherein the linolenic acid, linoleic acid, or combination thereof and the omega-3 fatty acid and the iron compound are dissolved in a vehicle including a saturated oil.
8 . A method of reducing unpleasant taste, regurgitation, gastroesophageal reflux, dyspepsia, or nausea associated with administration of a prenatal nutritional composition, the method comprising administering to a pregnant woman a composition comprising:
from about 50 mg to about 500 mg of calcium;
from about 100 mg to about 500 mg of omega-3 essential fatty acid from fish oil;
about 27 mg of carbonyl iron, soluble iron salts, slightly soluble iron salts, insoluble iron salts, chelated iron, iron complexes, and mixtures thereof;
from about 10 mg to about 300 mg of a linolenic acid compound, a linoleic acid compound, or a combination thereof;
about 25 mg of vitamin C;
from about 10 mg to about 150 mg of vitamin B 6 ;
from about 0.5 mg to about 3 mg of folic acid, folate, a derivative or metabolite thereof;
in a soft gelatin shell dosage form.
9 . A method for administering a nutritional supplement, the method comprising:
orally administering to a pregnant or lactating woman a capsule comprising; at least one essential fatty acid selected from the group consisting of at least one essential fatty acid, at least one essential fatty acid precursor, at least one derivative of an essential fatty acid and mixtures thereof; and
at least one pharmaceutically acceptable iron compound that is non-reactive with the at least one essential fatty acid;
wherein said nutritional supplement is provided in a soft gelatin shell dosage.